EL
25
4
PVH
62
5
AN
58
4
FSLR
54
7
AVY
53
3
ADSK
70
2
TROW
56
5
EFX
38
2
PNC
64
4
URI
65
5
WFC
79
4
ACN
52
3
CF
57
-2
EQT
57
-2
DVN
21
3
INTC
33
-2
RHI
59
2
DHI
48
4
PSX
47
2
WDC
47
4
EL
25
4
PVH
62
5
AN
58
4
FSLR
54
7
AVY
53
3
ADSK
70
2
TROW
56
5
EFX
38
2
PNC
64
4
URI
65
5
WFC
79
4
ACN
52
3
CF
57
-2
EQT
57
-2
DVN
21
3
INTC
33
-2
RHI
59
2
DHI
48
4
PSX
47
2
WDC
47
4
Financhill
Back

IDEXX Laboratories Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
44

IDXX
IDEXX Laboratories

Last Price:
417.11
Seasonality Move:
7.46%
Sell
28

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
-0.57%
Sell
44
IDEXX Laboratories (IDXX) is a Sell

Is IDEXX Laboratories a Buy, Sell or Hold?

  • The current IDEXX Laboratories [IDXX] share price is $417.24. The Score for IDXX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • IDXX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.68. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IDXX Stock Price Chart

What is IDEXX Laboratories's stock price today?

  • The IDEXX Laboratories share price today is $417.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IDXX is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

IDXX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.37 Sell
Relative Strength Index (14 RSI): 35.41 Sell
Chaikin Money Flow: -301246 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (415.9 - 447.94) Sell
Bollinger Bands (100): (444.29 - 498.19) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 48.48 Sell
Chaikin Money Flow: -30586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.28 - 1.42) Sell

IDXX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 420.63 Sell
20-day SMA: 426.07 Sell
50-day SMA: 461.65 Sell
200-day SMA: 495.44 Sell
8-day EMA: 420.55 Sell
20-day EMA: 429.54 Sell
50-day EMA: 449.78 Sell
200-day EMA: 480.36 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.71 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.66 Buy
200-day SMA: 2.33 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.7 Sell
50-day EMA: 0.73 Sell
200-day EMA: 5.57 Sell

IDEXX Laboratories Earnings Growth & IDXX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and an increase next year of $1.15 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

IDEXX Laboratories Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):